n-heptane has been researched along with Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alper, SL; Barešova, V; Bleyer, AJ; Carter, TA; Clark, AR; Deltas, C; Dvela-Levitt, M; Elonga, E; Emani, M; Gnirke, A; Golub, TR; Greka, A; Gutierrez, J; Hartland, K; Heiman, M; Hsu, JC; Hughey, R; Kmoch, S; Kohnert, E; Kost-Alimova, M; Kota, S; Lander, ES; McKinney, D; Melanson, M; Montesinos, MS; Papagregoriou, G; Rivadeneira, A; Roignot, J; Ronco, L; Roth, M; Sahakian, N; Schlondorff, J; Sidhom, EH; Thompson, R; Wagner, F; Weins, A; Wieder, N; Živná, M | 1 |
1 other study(ies) available for n-heptane and Kidney Diseases
| Article | Year |
|---|---|
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy.
Topics: Activating Transcription Factor 6; Animals; Benzamides; Bridged Bicyclo Compounds; Epithelial Cells; Female; Frameshift Mutation; Heptanes; Humans; Imidazoline Receptors; Induced Pluripotent Stem Cells; Kidney; Kidney Diseases; Lysosomes; Male; Mice; Mice, Transgenic; Mucin-1; RNA Interference; RNA, Small Interfering; Unfolded Protein Response; Vesicular Transport Proteins | 2019 |